Delivery Order SPE2DB20D2104-SPE2DB25F1130

Award Date 11/5/24
Potential Completion Date 11/6/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $12,280.32 firm-fixed-price contract is for the supply of DESCOVY 200-25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,535.79 firm-fixed-price contract is for the supply of DESCOVY 200-25 MG TABLET medical products, with a completion date of May 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET UU 30S, a prescription medication. The firm fixed-price contract, valued at $19,883.98, has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,440.09, is for the delivery of DESCOVY 200-25 MG TABLET medical supplies. The contract has an ultimate completion date of November 16, 2023 and a firm fixed price pricing type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of DESCOVY 200-25 MG TABLET medical supplies. The $6,622.48 firm-fixed-price delivery order has a completion date of June 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,693.07 firm fixed-price contract is for the supply of DESCOVY 200-25 MG TABLET, a prescription medication. The contract has an ultimate completion date of January 10, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $30,211.52 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the pharmaceutical product DESCOVY 200-25 MG TABLET. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,448.81, is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm-fixed price contract with an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for DESCOVY 200-25 MG TABLET medical supplies. The $2,747.25 Firm Fixed Price contract has an ultimate completion date of October 30, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,429.86 firm fixed-price contract is for the delivery of DESCOVY 200-25 MG TABLET, a pharmaceutical product, with a period of performance through July 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25F1130
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET. The $10,268.06 firm fixed-price contract has a completion date of November 6, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/4/25, 10:31 AM